• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For March 3, 2022

    3/3/22 4:46:21 AM ET
    $ABUS
    $ACR
    $ADCT
    $ADTH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate
    Get the next $ABUS alert in real time by email

     

    Companies Reporting Before The Bell

    • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.

    • Urban One (NASDAQ:UONEK) is likely to report earnings for its fourth quarter.

    • Tile Shop Holdings (NASDAQ:TTSH) is likely to report earnings for its fourth quarter.

    • Oxford Square Capital (NASDAQ:OXSQ) is estimated to report quarterly earnings at $0.09 per share on revenue of $10.30 million.

    • Aurora Mobile (NASDAQ:JG) is projected to report quarterly loss at $0.07 per share on revenue of $15.65 million.

    • Mobile TeleSystems (NYSE:MBT) is estimated to report quarterly earnings at $0.19 per share on revenue of $1.69 billion.

    • LENSAR (NASDAQ:LNSR) is estimated to report quarterly loss at $0.52 per share on revenue of $8.70 million.

    • Bluegreen Vacations (NYSE:BVH) is likely to report quarterly earnings at $0.62 per share on revenue of $203.89 million.

    • Fulcrum Therapeutics (NASDAQ:FULC) is projected to report quarterly loss at $0.73 per share on revenue of $2.68 million.

    • EyePoint Pharmaceuticals (NASDAQ:EYPT) is expected to report quarterly loss at $0.53 per share on revenue of $9.80 million.

    • Passage Bio (NASDAQ:PASG) is estimated to report earnings for its fourth quarter.

    • Boqii Holding (NYSE:BQ) is projected to report quarterly loss at $0.09 per share on revenue of $59.45 million.

    • GlycoMimetics (NASDAQ:GLYC) is estimated to report earnings for its fourth quarter.

    • MINISO Group Holding (NYSE:MNSO) is likely to report quarterly earnings at $0.08 per share on revenue of $422.86 million.

    • Crescent Point Energy (NYSE:CPG) is expected to report quarterly earnings at $0.22 per share on revenue of $666.90 million.

    • Revlon (NYSE:REV) is likely to report quarterly earnings at $0.06 per share on revenue of $645.60 million.

    • Toro (NYSE:TTC) is estimated to report quarterly earnings at $0.62 per share on revenue of $967.83 million.

    • Antares Pharma (NASDAQ:ATRS) is projected to report quarterly earnings at $0.01 per share on revenue of $46.69 million.

    • Concert Pharmaceuticals (NASDAQ:CNCE) is projected to report quarterly loss at $0.73 per share on revenue of $20.00 thousand.

    • Weibo (NASDAQ:WB) is likely to report quarterly earnings at $0.81 per share on revenue of $607.75 million.

    • Burlington Stores (NYSE:BURL) is expected to report quarterly earnings at $3.25 per share on revenue of $2.78 billion.

    • BJ's Wholesale Club (NYSE:BJ) is likely to report quarterly earnings at $0.74 per share on revenue of $4.38 billion.

    • argenx (NASDAQ:ARGX) is expected to report quarterly loss at $4.82 per share on revenue of $18.07 million.

    • Toronto-Dominion Bank (NYSE:TD) is projected to report quarterly earnings at $1.62 per share on revenue of $8.56 billion.

    • Best Buy Co (NYSE:BBY) is projected to report quarterly earnings at $2.73 per share on revenue of $16.59 billion.

    • Bilibili (NASDAQ:BILI) is projected to report quarterly loss at $0.68 per share on revenue of $913.86 million.

    • Kroger (NYSE:KR) is expected to report quarterly earnings at $0.74 per share on revenue of $32.86 billion.

    • Canadian Natural Res (NYSE:CNQ) is projected to report quarterly earnings at $1.65 per share on revenue of $6.82 billion.

    • Rain Therapeutics (NASDAQ:RAIN) is likely to report earnings for its fourth quarter.

    • HUTCHMED (China) (NASDAQ:HCM) is estimated to report earnings for its fourth quarter.

    • Fusion Fuel Green (NASDAQ:HTOO) is estimated to report earnings for its fourth quarter.

    • Via Renewables (NASDAQ:VIA) is likely to report earnings for its fourth quarter.

    • REE Automotive (NASDAQ:REE) is expected to report quarterly loss at $0.12 per share on revenue of $360.00 thousand.

    • Holley (NYSE:HLLY) is projected to report quarterly earnings at $0.12 per share on revenue of $148.58 million.

    • Utz Brands (NYSE:UTZ) is estimated to report quarterly earnings at $0.15 per share on revenue of $296.81 million.

    • ADC Therapeutics (NYSE:ADCT) is expected to report quarterly loss at $0.86 per share on revenue of $16.46 million.

    • Materialise (NASDAQ:MTLS) is estimated to report quarterly earnings at $0.04 per share on revenue of $59.74 million.

    • WAVE Life Sciences (NASDAQ:WVE) is likely to report quarterly loss at $0.51 per share on revenue of $15.79 million.

    • Sotherly Hotels (NASDAQ:SOHO) is estimated to report quarterly loss at $0.39 per share on revenue of $33.25 million.

    • Marcus (NYSE:MCS) is estimated to report quarterly loss at $0.18 per share on revenue of $154.31 million.

    • Brown Forman Inc Class B Common Stock (NYSE:BF) is estimated to report quarterly earnings at $0.47 per share on revenue of $983.13 million.

    • WhiteHorse Finance (NASDAQ:WHF) is likely to report quarterly earnings at $0.37 per share on revenue of $19.27 million.

    • Tecnoglass (NASDAQ:TGLS) is estimated to report quarterly earnings at $0.41 per share on revenue of $129.36 million.

    • Verona Pharma (NASDAQ:VRNA) is estimated to report earnings for its fourth quarter.

    • Stereotaxis (AMEX:STXS) is estimated to report quarterly loss at $0.05 per share on revenue of $7.73 million.

    • Methode Electronics (NYSE:MEI) is expected to report quarterly earnings at $0.72 per share on revenue of $281.60 million.

    • Altisource Portfolio (NASDAQ:ASPS) is projected to report quarterly loss at $0.77 per share on revenue of $39.56 million.

    • Gogo (NASDAQ:GOGO) is projected to report quarterly earnings at $0.08 per share on revenue of $89.67 million.

    • Superior Industries Intl (NYSE:SUP) is expected to report quarterly loss at $0.22 per share on revenue of $338.50 million.

    • Sprague Resources (NYSE:SRLP) is likely to report quarterly earnings at $0.34 per share on revenue of $968.22 million.

    • GMS (NYSE:GMS) is likely to report quarterly earnings at $1.74 per share on revenue of $1.13 billion.

    • CRA International (NASDAQ:CRAI) is expected to report quarterly earnings at $1.05 per share on revenue of $138.04 million.

    • Arbutus Biopharma (NASDAQ:ABUS) is likely to report quarterly loss at $0.19 per share on revenue of $2.87 million.

    • Big Lots (NYSE:BIG) is estimated to report quarterly earnings at $1.90 per share on revenue of $1.72 billion.

    • Titan Intl (NYSE:TWI) is expected to report quarterly earnings at $0.17 per share on revenue of $441.59 million.

    • Consolidated Comms Hldgs (NASDAQ:CNSL) is likely to report quarterly earnings at $0.04 per share on revenue of $318.84 million.

    • Brown Forman Inc Class A Common Stock (NYSE:BF) is likely to report earnings for its third quarter.

    • Canaan (NASDAQ:CAN) is expected to report earnings for its fourth quarter.

    • Sibanye Stillwater (NYSE:SBSW) is expected to report earnings for its Fiscal Year 2021.

    • Grab Hldgs (NASDAQ:GRAB) is estimated to report earnings for its fourth quarter.

     

    Companies Reporting After The Bell

    • Payoneer Global (NASDAQ:PAYO) is estimated to report quarterly loss at $0.02 per share on revenue of $126.29 million.

    • VIZIO Holding (NYSE:VZIO) is likely to report quarterly loss at $0.18 per share on revenue of $699.36 million.

    • Ooma (NYSE:OOMA) is expected to report quarterly earnings at $0.10 per share on revenue of $49.97 million.

    • CPS Technologies (NASDAQ:CPSH) is expected to report earnings for its fourth quarter.

    • AdTheorent Holding (NASDAQ:ADTH) is likely to report quarterly earnings at $0.02 per share on revenue of $50.81 million.

    • Vicarious Surgical (NYSE:RBOT) is estimated to report earnings for its fourth quarter.

    • EzFill Holdings (NASDAQ:EZFL) is likely to report quarterly loss at $0.10 per share on revenue of $2.00 million.

    • PowerSchool Holdings (NYSE:PWSC) is projected to report quarterly earnings at $0.09 per share on revenue of $141.69 million.

    • Duolingo (NASDAQ:DUOL) is expected to report quarterly loss at $0.68 per share on revenue of $68.88 million.

    • DBV Technologies (NASDAQ:DBVT) is estimated to report quarterly loss at $0.54 per share on revenue of $2.21 million.

    • Treace Medical Concepts (NASDAQ:TMCI) is estimated to report earnings for its fourth quarter.

    • Agilon Health (NYSE:AGL) is expected to report quarterly loss at $0.11 per share on revenue of $452.89 million.

    • Intl General Insurance (NASDAQ:IGIC) is expected to report quarterly earnings at $0.23 per share on revenue of $148.90 million.

    • Entravision Comms (NYSE:EVC) is estimated to report quarterly earnings at $0.15 per share on revenue of $226.40 million.

    • Banco BBVA Argentina (NYSE:BBAR) is likely to report quarterly earnings at $0.21 per share on revenue of $236.94 million.

    • Trinity Capital (NASDAQ:TRIN) is expected to report quarterly earnings at $0.41 per share on revenue of $22.18 million.

    • PerkinElmer (NYSE:PKI) is expected to report quarterly earnings at $0.22 per share on revenue of $5.58 billion.

    • Montrose Environmental Gr (NYSE:MEG) is estimated to report quarterly earnings at $0.33 per share on revenue of $1.18 billion.

    • Grid Dynamics Holdings (NASDAQ:GDYN) is likely to report quarterly earnings at $0.08 per share on revenue of $58.55 million.

    • Algonquin Power (NYSE:AQN) is expected to report quarterly earnings at $0.28 per share on revenue of $690.81 million.

    • Invesco DWA Industrials Momentum ETF (NASDAQ:PRN) is estimated to report quarterly loss at $0.42 per share on revenue of $3.25 million.

    • Atreca (NASDAQ:BCEL) is projected to report earnings for its fourth quarter.

    • Gossamer Bio (NASDAQ:GOSS) is likely to report earnings for its fourth quarter.

    • Puma Biotechnology (NASDAQ:PBYI) is likely to report quarterly loss at $0.09 per share on revenue of $47.17 million.

    • Fidus Investment (NASDAQ:FDUS) is expected to report quarterly earnings at $0.36 per share on revenue of $20.53 million.

    • Funko (NASDAQ:FNKO) is estimated to report quarterly earnings at $0.24 per share on revenue of $272.49 million.

    • AeroVironment (NASDAQ:AVAV) is expected to report quarterly earnings at $0.30 per share on revenue of $106.72 million.

    • Cellectis (NASDAQ:CLLS) is likely to report quarterly loss at $0.92 per share on revenue of $8.72 million.

    • Calyxt (NASDAQ:CLXT) is likely to report quarterly loss at $0.41 per share on revenue of $2.64 million.

    • Great Ajax (NYSE:AJX) is projected to report quarterly earnings at $0.38 per share on revenue of $20.51 million.

    • Gap (NYSE:GPS) is expected to report quarterly loss at $0.14 per share on revenue of $4.49 billion.

    • Costco Wholesale (NASDAQ:COST) is projected to report quarterly earnings at $2.73 per share on revenue of $51.37 billion.

    • SIGA Technologies (NASDAQ:SIGA) is estimated to report earnings for its fourth quarter.

    • Smith & Wesson Brands (NASDAQ:SWBI) is likely to report quarterly earnings at $0.86 per share on revenue of $198.29 million.

    • Sweetgreen (NYSE:SG) is likely to report quarterly loss at $0.66 per share on revenue of $84.71 million.

    • Cvent Holding (NASDAQ:CVT) is projected to report quarterly earnings at $0.02 per share on revenue of $140.72 million.

    • Arteris (NASDAQ:AIP) is estimated to report quarterly loss at $0.17 per share on revenue of $10.70 million.

    • Runway Growth Finance (NASDAQ:RWAY) is likely to report quarterly earnings at $0.26 per share on revenue of $18.12 million.

    • Xponential Fitness (NYSE:XPOF) is likely to report quarterly loss at $0.14 per share on revenue of $42.03 million.

    • Integral Ad Science (NASDAQ:IAS) is likely to report quarterly loss at $0.01 per share on revenue of $94.83 million.

    • Enovix (NASDAQ:ENVX) is estimated to report quarterly loss at $0.15 per share on revenue of $750.00 thousand.

    • Alignment Healthcare (NASDAQ:ALHC) is estimated to report quarterly loss at $0.30 per share on revenue of $269.57 million.

    • Evolus (NASDAQ:EOLS) is estimated to report quarterly loss at $0.19 per share on revenue of $33.99 million.

    • Chembio Diagnostics (NASDAQ:CEMI) is projected to report quarterly loss at $0.20 per share on revenue of $13.55 million.

    • National CineMedia (NASDAQ:NCMI) is projected to report quarterly loss at $0.04 per share on revenue of $67.80 million.

    • Oncolytics Biotech (NASDAQ:ONCY) is expected to report earnings for its fourth quarter.

    • Veritone (NASDAQ:VERI) is estimated to report quarterly earnings at $0.20 per share on revenue of $44.80 million.

    • Salem Media Group (NASDAQ:SALM) is projected to report quarterly earnings at $0.06 per share on revenue of $66.59 million.

    • Issuer Direct (AMEX:ISDR) is likely to report earnings for its fourth quarter.

    • INmune Bio (NASDAQ:INMB) is expected to report earnings for its fourth quarter.

    • First Eagle Alternative (NASDAQ:FCRD) is expected to report quarterly earnings at $0.10 per share on revenue of $8.43 million.

    • Eagle Bulk Shipping (NASDAQ:EGLE) is expected to report quarterly earnings at $6.00 per share on revenue of $152.12 million.

    • Crawford & Company Common Stock (NYSE:CRD) is estimated to report quarterly earnings at $0.18 per share on revenue of $277.96 million.

    • ACRES Commercial Realty (NYSE:ACR) is projected to report quarterly earnings at $0.14 per share on revenue of $11.90 million.

    • Profound Medical (NASDAQ:PROF) is projected to report quarterly loss at $0.37 per share on revenue of $3.00 million.

    • FedNat Holding (NASDAQ:FNHC) is projected to report quarterly loss at $1.02 per share on revenue of $69.59 million.

    • Aziyo Biologics (NASDAQ:AZYO) is expected to report quarterly loss at $0.68 per share on revenue of $11.06 million.

    • Elastic (NYSE:ESTC) is expected to report quarterly loss at $0.21 per share on revenue of $209.36 million.

    • Quanex Building Prods (NYSE:NX) is projected to report quarterly earnings at $0.26 per share on revenue of $242.89 million.

    • Crawford & Company Common Stock (NYSE:CRD) is estimated to report earnings for its fourth quarter.

    • Cooper Companies (NYSE:COO) is estimated to report quarterly earnings at $3.10 per share on revenue of $744.34 million.

    • Marvell Technology (NASDAQ:MRVL) is estimated to report quarterly earnings at $0.48 per share on revenue of $1.32 billion.

    • Broadcom (NASDAQ:AVGO) is likely to report quarterly earnings at $8.08 per share on revenue of $7.60 billion.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ABUS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABUS
    $ACR
    $ADCT
    $ADTH

    CompanyDatePrice TargetRatingAnalyst
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Hold
    Truist
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Neutral
    BofA Securities
    Xponential Fitness Inc.
    $XPOF
    2/27/2026$7.00Buy → Neutral
    Roth Capital
    Costco Wholesale Corporation
    $COST
    2/27/2026$1185.00Buy
    BofA Securities
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Sector Outperform → Sector Perform
    Scotiabank
    Duolingo Inc.
    $DUOL
    2/27/2026$95.00Overweight → Neutral
    Analyst
    Duolingo Inc.
    $DUOL
    2/27/2026$114.00Outperform → In-line
    Evercore ISI
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $ABUS
    $ACR
    $ADCT
    $ADTH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-5) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:04:01 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZYNLONTA issued to ADC Therapeutics SA

    Submission status for ADC Therapeutics SA's drug ZYNLONTA (SUPPL-4) with active ingredient LONCASTUXIMAB TESIRINE-LPYL has changed to 'Approval' on 10/12/2022. Application Category: BLA, Application Number: 761196, Application Classification:

    10/13/22 1:03:14 PM ET
    $ADCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TESTOSTERONE UNDECANOATE issued to ANTARES PHARMA INC

    Submission status for ANTARES PHARMA INC's drug TESTOSTERONE UNDECANOATE (ORIG-1) with active ingredient TESTOSTERONE UNDECANOATE has changed to 'Approval' on 03/28/2022. Application Category: NDA, Application Number: 208088, Application Classification: Type 3 - New Dosage Form

    3/30/22 12:07:58 PM ET
    $ATRS
    Medical/Dental Instruments
    Health Care

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Duolingo downgraded by Truist with a new price target

    Truist downgraded Duolingo from Buy to Hold and set a new price target of $100.00

    2/27/26 12:55:49 PM ET
    $DUOL
    Computer Software: Prepackaged Software
    Technology

    Duolingo downgraded by BofA Securities with a new price target

    BofA Securities downgraded Duolingo from Buy to Neutral and set a new price target of $100.00

    2/27/26 10:22:22 AM ET
    $DUOL
    Computer Software: Prepackaged Software
    Technology

    Xponential Fitness downgraded by Roth Capital with a new price target

    Roth Capital downgraded Xponential Fitness from Buy to Neutral and set a new price target of $7.00

    2/27/26 8:34:02 AM ET
    $XPOF
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $ABUS
    $ACR
    $ADCT
    $ADTH
    SEC Filings

    View All

    Amendment: SEC Form N-14 8C/A filed by Runway Growth Finance Corp.

    N-14 8C/A - Runway Growth Finance Corp. (0001653384) (Filer)

    2/27/26 5:12:01 PM ET
    $RWAY
    Finance: Consumer Services
    Finance

    Grid Dynamics Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K - GRID DYNAMICS HOLDINGS, INC. (0001743725) (Filer)

    2/27/26 4:15:43 PM ET
    $GDYN
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-Q filed by Elastic N.V.

    10-Q - Elastic N.V. (0001707753) (Filer)

    2/27/26 4:08:28 PM ET
    $ESTC
    Computer Software: Prepackaged Software
    Technology

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Global Chief Executive Officer Bartel Holger bought $1,077,000 worth of shares (200,000 units at $5.38) (SEC Form 4)

    4 - TRAVELZOO (0001133311) (Issuer)

    2/24/26 4:44:54 PM ET
    $TZOO
    Advertising
    Consumer Discretionary

    Director Pisano Wayne bought $25,338 worth of shares (30,000 units at $0.84), increasing direct ownership by 6% to 492,414 units (SEC Form 4)

    4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)

    2/13/26 7:00:29 AM ET
    $ONCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Kelly Jared bought $29,521 worth of shares (35,100 units at $0.84), increasing direct ownership by 47% to 109,000 units (SEC Form 4)

    4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)

    2/13/26 7:00:32 AM ET
    $ONCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Francis Chris exercised 33,194 units of Ordinary Shares at a strike of $4.28 and sold $499,593 worth of Ordinary Shares (33,194 units at $15.05) (SEC Form 4)

    4 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    2/27/26 9:00:03 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Hughes Bradley E.

    4 - Quanex Building Products CORP (0001423221) (Issuer)

    2/27/26 5:29:48 PM ET
    $NX
    Metal Fabrications
    Industrials

    Director Raza Saiyed Atiq sold $1,545,260 worth of shares (90,279 units at $17.12) (SEC Form 4)

    4 - Arteris, Inc. (0001667011) (Issuer)

    2/27/26 5:22:41 PM ET
    $AIP
    Semiconductors
    Technology

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Methode Electronics Announces Third Quarter Fiscal 2026 Results Conference Call

    SOUTHFIELD, Mich., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE:MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, announced it will conduct a conference call and webcast on Friday, March 6, 2026, at 11:00 a.m. EST to review its third quarter fiscal 2026 results. President and Chief Executive Officer, Jon DeGaynor, and Chief Financial Officer, Laura Kowalchik will lead the call. The presentation will be webcast live on the company's investor relations website at https://ir.methode.com. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the pres

    2/27/26 4:11:00 PM ET
    $MEI
    Electrical Products
    Technology

    AV, Inc. to Announce Third Quarter of Fiscal Year 2026 Earnings and Host Conference Call

    AeroVironment, Inc. ("AV") (NASDAQ:AVAV) will report its financial results for the third quarter of fiscal year 2026, which ended January 31, 2026, after the market closes on March 10, 2026. Management will host a conference call and live audio webcast at 4:30 p.m. Eastern Time that same day to discuss the results. The call will be led by Wahid Nawabi, AV's chairman, president, and chief executive officer; Kevin P. McDonnell, executive vice president and chief financial officer; and Denise Pacioni, head investor relations officer. Investors may access the conference call by registering through the following link up to 10 minutes before the event begins: Conference Call Details Date:

    2/27/26 3:24:00 PM ET
    $AVAV
    Aerospace
    Industrials

    Utz Brands Showcases New Chips, Pretzels and Bestsellers at Natural Products Expo West

    Boulder Canyon showcases innovation including tortilla chip lineup and new Boulder Batch Agave Sriracha Flavored Potato Chips and Utz debuts new line of Protein Pretzels and Cheese Curls Utz Brands, Inc., a leading U.S. manufacturer of branded salty snack foods will showcase new innovative products from Boulder Canyon® and Utz® at Booth 1117 in Hall A at the 2026 Natural Products Expo West, held March 4-6 at the Anaheim Convention Center in Anaheim, CA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227548219/en/Utz Brands Showcases New Chips, Pretzels and Bestsellers at Natural Products Expo West (Source: Utz Brands, Inc.)

    2/27/26 12:00:00 PM ET
    $UTZ
    Packaged Foods
    Consumer Staples

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Leadership Updates

    Live Leadership Updates

    View All

    AV Announces Retirement of Chief Financial Officer Kevin McDonnell

    AeroVironment, Inc. ("AV" or the "Company") (NASDAQ:AVAV), a global defense technology leader, today announced that Kevin McDonnell, Executive Vice President and Chief Financial Officer, has informed the Company of his decision to retire from AV, effective July 31, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260223105811/en/McDonnell joined AV in 2020. During his tenure as CFO, AV strengthened its balance sheet, enhanced its financial and operational discipline, completed strategic acquisitions and organic growth initiatives, and reinforced its capital allocation framework to drive long-term shareholder value. "Kevin ha

    2/23/26 5:13:00 PM ET
    $AVAV
    Aerospace
    Industrials

    Utz Brands Highlights Long Term Strategy and Differentiated Growth at 2026 CAGNY Conference

    Utz Brands, Inc. (NYSE:UTZ) ("Utz" or the "Company"), a leading U.S. manufacturer of branded Salty Snacks and a small-cap value Staples equity, will discuss its strategies and long-term growth targets today at the 2026 Consumer Analyst Group of New York (CAGNY) Conference. Chief Executive Officer, Howard Friedman, and EVP and Chief Financial Officer, BK Kelley, will outline how the Company plans to deliver sustainable growth and acceleration of free cash flow as the Company exits a capital-intensive transformation stage. "As the largest pure-play salty snack company in the country, we are focused on driving growth faster than the category," Friedman said. "We believe that prioritizing con

    2/18/26 7:00:00 AM ET
    $UTZ
    Packaged Foods
    Consumer Staples

    EyePoint Appoints Michael Campbell as Chief Commercial Officer

    – Seasoned commercial executive with over 30 years of leadership in retinal disease across biotech and large pharma –– Brings established track record of successful product launches and oversight of prominent ophthalmology franchises, including Lucentis® and Xiidra® – WATERTOWN, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Michael Campbell has been appointed Chief Commercial Officer. Mr. Campbell, an experienced commercial leader with a proven track record of successful product launches and oversight of

    2/18/26 7:00:00 AM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Montrose Environmental Group Inc.

    SC 13G - Montrose Environmental Group, Inc. (0001643615) (Subject)

    12/17/24 4:20:32 PM ET
    $MEG
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Fusion Fuel Green PLC

    SC 13G/A - Fusion Fuel Green PLC (0001819794) (Subject)

    12/11/24 4:02:05 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13G filed by Sotherly Hotels Inc.

    SC 13G - Sotherly Hotels Inc. (0001301236) (Subject)

    12/9/24 11:56:15 AM ET
    $SOHO
    Real Estate Investment Trusts
    Real Estate

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Financials

    Live finance-specific insights

    View All

    Methode Electronics Announces Third Quarter Fiscal 2026 Results Conference Call

    SOUTHFIELD, Mich., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE:MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, announced it will conduct a conference call and webcast on Friday, March 6, 2026, at 11:00 a.m. EST to review its third quarter fiscal 2026 results. President and Chief Executive Officer, Jon DeGaynor, and Chief Financial Officer, Laura Kowalchik will lead the call. The presentation will be webcast live on the company's investor relations website at https://ir.methode.com. Participants are encouraged to log on to the webcast approximately 10 minutes before the start of the pres

    2/27/26 4:11:00 PM ET
    $MEI
    Electrical Products
    Technology

    AV, Inc. to Announce Third Quarter of Fiscal Year 2026 Earnings and Host Conference Call

    AeroVironment, Inc. ("AV") (NASDAQ:AVAV) will report its financial results for the third quarter of fiscal year 2026, which ended January 31, 2026, after the market closes on March 10, 2026. Management will host a conference call and live audio webcast at 4:30 p.m. Eastern Time that same day to discuss the results. The call will be led by Wahid Nawabi, AV's chairman, president, and chief executive officer; Kevin P. McDonnell, executive vice president and chief financial officer; and Denise Pacioni, head investor relations officer. Investors may access the conference call by registering through the following link up to 10 minutes before the event begins: Conference Call Details Date:

    2/27/26 3:24:00 PM ET
    $AVAV
    Aerospace
    Industrials

    Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results

    PONTE VEDRA, Fla., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the fourth quarter and full-year ended December 31, 2025. Recent Highlights Generated revenue of $62.5 million in fourth quarter 2025 and revenue of $212.7 million for the full-year 2025, an increase of 2% compared to the prior year.Reported fourth quarter 2025 net loss of $(9.4) million and adjusted EBITDA of $6.2 million in the fourth quarter 2025. Reported full-year 2025 net loss of $(59.0) million c

    2/27/26 7:05:00 AM ET
    $TMCI
    Medical/Dental Instruments
    Health Care

    $ABUS
    $ACR
    $ADCT
    $ADTH
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care